Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α)

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 122-133

  Vordermark, Dirk ^a   Kraft, Peter ^a   Katzer, Astrid ^a   Bölling, Tobias ^a   Willner, Jochen ^a   Flentje, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Hypoxia markers; Hypoxia inducible factor 1 ; Radiosensitivity; Tumor hypoxia; Tumor microenvironment

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CARCINOGENICITY; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FIBROSARCOMA; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; PH; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INDUCTION; RADIOSENSITIVITY; REPORTER GENE; SERUM; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARCINOMA; CELL HYPOXIA; FIBROSARCOMA; FLOW CYTOMETRY; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, SCID; PHARYNGEAL NEOPLASMS; RADIATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 27144439058     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.040     Document Type: Article

References (34)

1. M. Nordsmark, and J. Overgaard A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy Radiother. Oncol. 57 2000 39 43
2. M. Nordsmark, J. Alsner, J. Keller, O.S. Nielsen, O.M. Jensen, and M.R. Horsman Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations Br. J. Cancer 84 2001 1070 1075
3. A. Fyles, M. Milosevic, D. Hedley, M. Pintilie, W. Levin, and L. Manchul Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer J. Clin. Oncol. 20 2002 680 687
4. J.H. Kaanders, K.I. Wijffels, H.A. Marres, A.S. Ljungkvist, L.A. Pop, and F.J. van den Hoogen Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res. 62 2002 7066 7074
5. S.M. Evans, and C.J. Koch Prognostic significance of tumor oxygenation in humans Cancer Lett. 195 2003 1 16
6. D. Vordermark, and J.M. Brown Endogenous markers of tumor hypoxia: predictors of clinical radiation resistance? Strahlenther Onkol 179 2003 8011 8018
7. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47
8. D.M. Aebersold, P. Burri, K.T. Beer, J. Laissue, V. Djonov, and R.H. Greiner Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer Cancer Res. 61 2001 2911 2916
9. M.I. Koukourakis, A. Giatromanolaki, E. Sivridis, C. Simopoulos, H. Turley, and K. Talks Hypoxia-inducible factor (HIF 1A and HIF 2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer Int. J. Radiat. Oncol. Biol. Phys. 53 2002 1192 1202
10. E.P. Hui, A.T. Chan, F. Pezzella, H. Turley, K.F. To, and T.C. Poon Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival Clin. Cancer Res. 8 2002 2595 2604
11. H.L. Janssen, K.M. Haustermans, D. Sprong, G. Blommestijn, I. Hofland, and F.J. Hoebers HIF-1alpha, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors Int. J. Radiat. Oncol. Biol. Phys. 54 2002 1537 1549
12. H.K. Haugland, V. Vukovic, M. Pintilie, A.W. Fyles, M. Milosevic, and R.P. Hill Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation Int. J. Radiat. Oncol. Biol. Phys. 53 2002 854 861
13. D. Vordermark, A. Katzer, K. Baier, P. Kraft, and M. Flentje Cell-type specific association of hypoxia-inducible factor-1 ((HIF-1α) protein accumulation and radiobiologic tumor hypoxia Int. J. Radiat. Oncol. Biol. Phys. 58 2004 1242 1250
14. A. El-Said, D. Menke, M.J. Dorie, and J.M. Brown Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation Radiat. Oncol. Investig. 7 1999 163 169
15. D. Vordermark, and J.M. Brown Evaluation of hypoxia-inducible factor-1α (HIF-1α) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies Int. J. Radiat. Oncol. Biol. Phys. 56 2003 1184 1193
16. T. Shibata, A.J. Giaccia, and J.M. Brown Development of a hypoxia-responsive vector for tumor-specific gene therapy Gene Ther. 7 2000 493 498
17. D. Vordermark, T. Shibata, and J.M. Brown Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation Neoplasia 3 2001 527 534
18. D. Vordermark, D.R. Menke, and J.M. Brown Similar radiation sensitivities of acutely and chronically hypoxic cells in HT 1080 fibrosarcoma xenografts Radiat Res. 159 2003 94 101
19. C. Petersen, W. Eicheler, A. Frömmel, M. Krause, S. Balschukat, and D. Zips Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice Int. J. Radiat. Biol. 79 2003 469 477
20. S.A. Hill, D.R. Collingridge, B. Vojnovic, and D.J. Chaplin Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity Int. J. Radiat. Oncol. Biol. Phys. 40 1998 943 951
21. M.W. Gross, U. Karbach, K. Groebe, A.J. Franko, and W. Mueller-Klieser Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids Int. J. Cancer 61 1995 567 573
22. G.G. Steel Basic clinical radiobiology second ed. 1997 Arnold London
23. P.L. Olive, C. Aquino-Parsons, S.H. MacPhail, S.Y. Liao, J.A. Raleigh, and M.I. Lerman Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer Cancer Res. 61 2001 8924 8929
24. H. Lu, R.A. Forbes, and A. Verma Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis J. Biol. Chem. 277 2002 23111 23115
25. D. Lando, J.J. Gorman, M.L. Whitelaw, and D.J. Peet Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparyginyl hydroxylation Eur. J. Biochem. 270 2003 781 790
26. T. Kietzmann, A. Krones-Herzig, and K. Jungermann Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements Biochem. Pharmacol. 64 2002 903 911
27. H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, and M.M. Georgescu Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res. 60 2000 1541 1545
28. H. Zhong, N. Mabjeesh, M. Willard, and J.W. Simons Nuclear expression of hypoxia -inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions Cancer Lett. 181 2002 233 238
29. L. Xu, and I.J. Fidler Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells Cancer Res. 60 2000 4610 4616
30. V. Vukovic, H.K. Haugland, T. Nicklee, A.J. Morrison, and D.W. Hedley Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts Cancer Res. 61 2001 7394 7398
31. S. Walenta, S. Snyder, Z.A. Haroon, R.D. Braun, K. Amin, and D. Brizel Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model Int. J. Radiat. Oncol. Biol. Phys. 51 2001 840 848
32. W. Mueller-Klieser, P. Vaupel, and C. Streffer Energy status of malignant tumors in patients and experimental animals M. Molls P. Vaupel Blood perfusion and microenvironment of human tumors 2000 Springer Berlin 121 132
33. T. Shibata, A.J. Giaccia, and J.M. Brown Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy Neoplasia 4 2002 40 48
34. G.U. Dachs, A.V. Patterson, J.D. Firth, P.J. Ratcliffe, K.M. Townsend, and I.J. Stratford Targeting gene expression to hypoxic tumor cells Nat. Med. 3 1997 515 520